Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06173453
Status:
RECRUITING
Last Update Posted:
2023-12-15
First Post:
2023-06-15
Brief Title:
Factors Associated With Survival in Patients Having Pneumocystis Jirovecii
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Factors Associated With Survival in Patients With a Positive Sample for Pneumocystis Jirovecii at the Strasbourg University Hospital a Retrospective Study From 2016 to 2018
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
JIROVECI
Brief Summary:
Pneumocystis jirovecii is a fungus that can colonize the airways of some patients and be responsible for a disease called pneumocystosis in other patients and mainly in immunocompromised patients
Pneumocystosis was mainly linked to HIV in the 1990s but with the advent of new immunosuppressive molecules used in cancers or autoimmune diseases and with the increase in the number of transplants the epidemiology has changed in recent years
Studies on P jirovecii-related mortality are only based on patients with pneumocystosis As a result patients who are simply colonized or patients who are sick but not treated are not taken into account in these studies The investigators therefore wish to study the overall mortality at six weeks and at three months in all patients with a positive sample for P jirovecii
Pneumocystosis was mainly linked to HIV in the 1990s but with the advent of new immunosuppressive molecules used in cancers or autoimmune diseases and with the increase in the number of transplants the epidemiology has changed in recent years
Studies on P jirovecii-related mortality are only based on patients with pneumocystosis As a result patients who are simply colonized or patients who are sick but not treated are not taken into account in these studies The investigators therefore wish to study the overall mortality at six weeks and at three months in all patients with a positive sample for P jirovecii
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None